Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

NCT06361537 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

124

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Hereditary Angio Edema

Interventions

DRUG: OCTA-C1-INH
OTHER: Placebo

Sponsor

Octapharma